These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10959621)

  • 1. Meeting the evolving therapeutic needs of postmenopausal women.
    Ettinger B
    J Bone Miner Metab; 2000; 18(5):299-304. PubMed ID: 10959621
    [No Abstract]   [Full Text] [Related]  

  • 2. [What do we think about selective estrogen receptor modulators?].
    Cortet B
    Rev Med Interne; 2001 Dec; 22(12):1173-6. PubMed ID: 11794886
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosis.
    Hayashi T; Ina K; Maeda M; Nomura H
    Nitric Oxide; 2011 May; 24(4):199-203. PubMed ID: 21513812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of postmenopausal osteoporosis with raloxifene].
    Fedelesova V; Chylova K; Dzurik
    Bratisl Lek Listy; 2000; 101(9):527-8. PubMed ID: 11187059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raloxifene: a new choice for treating and preventing osteoporosis.
    Licata AA; Ciaccia AV; Wong M; Draper MW
    Cleve Clin J Med; 2000 Apr; 67(4):273-80. PubMed ID: 10780099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants.
    Lippman ME; Krueger KA; Eckert S; Sashegyi A; Walls EL; Jamal S; Cauley JA; Cummings SR
    J Clin Oncol; 2001 Jun; 19(12):3111-6. PubMed ID: 11408508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of raloxifene, estrogen, and hormone replacement therapy on serum homocysteine levels in postmenopausal women.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Rizos D; Coutoukos J; Creatsas G
    Fertil Steril; 2003 Feb; 79(2):455-6. PubMed ID: 12568869
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women.
    Walsh BW; Cox DA; Sashegyi A; Dean RA; Tracy RP; Anderson PW
    Am J Cardiol; 2001 Oct; 88(7):825-8. PubMed ID: 11589863
    [No Abstract]   [Full Text] [Related]  

  • 10. Uterine effects of raloxifene in comparison with continuous-combined hormone replacement therapy in postmenopausal women.
    Fugère P; Scheele WH; Shah A; Strack TR; Glant MD; Jolly E
    Am J Obstet Gynecol; 2000 Mar; 182(3):568-74. PubMed ID: 10739509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raloxifene examined for breast cancer prevention.
    Young D
    Am J Health Syst Pharm; 2007 Sep; 64(17):1774. PubMed ID: 17724350
    [No Abstract]   [Full Text] [Related]  

  • 12. Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis?
    Gold DT; Silverman SL
    Curr Osteoporos Rep; 2007 Mar; 5(1):3-7. PubMed ID: 17320021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERT, HRT, raloxifine, calcitonin, or bisphosphonates for osteoporosis.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(2):178-81. PubMed ID: 14613350
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raloxifene trial in postmenopausal woman with treatment-resistant schizophrenia.
    Tharoor H; Goyal A
    Arch Womens Ment Health; 2015 Oct; 18(5):741-2. PubMed ID: 26189131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of postmenopausal osteoporosis].
    Keck E
    Orthopade; 2003 Dec; 32(12):1104-9. PubMed ID: 14655007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications for hormone replacement therapy].
    Birkhäuser MH
    Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specific estrogen receptor modulators (SERMs)].
    Trémollières F; Lopes P
    Presse Med; 2002 Sep; 31(28):1323-8. PubMed ID: 12355995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective estrogen receptor modulators.
    Kearney CE; Purdie DW
    Climacteric; 1998 Jun; 1(2):143-7. PubMed ID: 11907917
    [No Abstract]   [Full Text] [Related]  

  • 20. Estrogen and atherothrombosis.
    Dayspring T
    Am J Cardiol; 2000 Aug; 86(4):482-3. PubMed ID: 10946054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.